David Lang
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization (NCT00555971) | David Lang | 2006-05-01 |
Track David Lang automatically
Every clearance here is in the API, with alerts when new ones post.